<DOC>
	<DOCNO>NCT02077712</DOCNO>
	<brief_summary>2 ug/kg intranasal dexmedetomidine could produce satisfactory sedation child ophthalmic examination sedative effect 1ug/kg .</brief_summary>
	<brief_title>Intranasal Dexmedetomidine Sedation Ophthalmic Examinations Children</brief_title>
	<detailed_description>Dexmedetomidine a2-adrenergic receptor agonist provide sedation without respiratory depression.Clinical trial demonstrate intranasal dexmedetomidine dose 1ug/kg produce satisfactory sedation 53 % 57 % child anaesthetic induction . There also report use high dos intranasal dexmedetomidine . The investigator compare sedative effect 1ug/kg intranasal dexmedetomidine 2 ug/kg ophthalmic examination child age 2 months-10 year hypothesise high dose would produce satisfactory sedation child time anaesthetic induction .</detailed_description>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Need sedation ophthalmic examination Children fail chloral hydrate sedation , i.e.there evidence sedation 30 min follow administration . With informed consent parent Children gastroesophageal reflux Children nausea vomit Children apnea past three month Children recent pneumonia , exacerbation asthma , bronchitis upper respiratory tract infection Children severe arrhythmia , heart failure cardiac structural abnormality Children facial abnormality , expect difficult effective mask ventilation Children severe neurological disease Children moyamoya disease Children allergy For dexmedetomidine chloral hydrate Preterm child , weight &lt; 2 kg</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>